4513 Butyrylcarnitine Butyrylcarnitine is elevated in patients with acyl-coa dehydrogenase, short-chain (SCAD) deficiencyin; in infants with acute acidosis and generalized muscle weakness; and in middle-aged patients with chronic myopathy localized in muscle. (OMIM 201470). 25576-40-3 439829 C11H21NO4 White powder. No indication of carcinogenicity to humans (not listed by IARC). This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation. 2014-08-29T06:51:29Z 2026-04-06T12:54:43Z C02862 true CCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C C11H21NO4 InChI=1S/C11H21NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h9H,5-8H2,1-4H3 QWYFHHGCZUCMBN-UHFFFAOYSA-N 231.2887 231.147058165 Endogenous Solid HMDB02013 CHEMBL2074693 388877 Lozano Pedro; Daz Mirta; de Diego Teresa; Iborra Jose L Ester synthesis from trimethylammonium alcohols in dry organic media catalyzed by immobilized Candida antarctica lipase B. Biotechnology and bioengineering (2003), 82(3), 352-8. CHEM003419 NS00124845 66.43 81.8647 24.796522551548037 8 3 0 4.26892391250365 -7.057078620656008 0 0 -2.10 -3.74 5.23e-02 g/l